|
Men
|
|
Positive screen based on AUDIT-C score
|
|
AUDIT-C score
|
% reporting < recommended limits
|
|
Total
|
Q#1
|
Q#2
|
Q#3
|
%
|
(95% CI)
|
%
|
(95% CI)
|
|
4
|
3
|
1
|
0
|
2.3
|
(2.1–2.6)
|
1.0
|
(1.0-1.0)
|
|
4
|
4
|
0
|
0
|
5.4
|
(5.1–5.8)
|
12.9
|
(12.7–13.0)
|
|
5
|
4
|
1
|
0
|
1.1
|
(0.9–1.3)
|
1.9
|
(1.8–1.9)
|
|
All inconsistent positive screens
|
8.9*
|
(8.4–9.4)
|
15.8
|
(15.6–15.8)
|
|
Negative screen based on AUDIT-C score
|
|
AUDIT-C score
|
% reporting > recommended limits
|
|
Total
|
Q#1
|
Q#2
|
Q#3
|
%
|
(95% CI)
|
%
|
(95% CI)
|
|
2
|
1
|
0
|
1
|
1.1
|
(0.9–1.2)
|
2.0
|
(2.0–2.0)
|
|
3
|
1
|
1
|
1
|
2.0
|
(1.7–2.2)
|
0.6
|
(0.6–0.6)
|
|
3
|
1
|
0
|
2
|
0
|
--
|
0.3
|
(0.3–0.3)
|
|
3
|
1
|
2
|
0
|
0
|
--
|
0.1
|
(0.01-0.1)
|
|
3
|
2
|
0
|
1
|
1.9
|
(1.7–2.2)
|
2.3
|
(2.2–2.3)
|
|
All inconsistent negative screens
|
4.9
|
(4.6–5.3)
|
5.3
|
(5.2–5.3)
|
|
All inconsistent negative & positive screens
|
13.8
|
(13.2–14.4)
|
21.1
|
(20.9–21.1)
|
|
Women
|
|
Positive screen based on AUDIT-C score
|
|
AUDIT-C score
|
% reporting < recommended limits **
|
|
Total
|
Q#1
|
Q#2
|
Q#3
|
%
|
(95% CI)
|
%
|
(95% CI)
|
|
3
|
2
|
1
|
0
|
2.6
|
(2.4–2.9)
|
1.5
|
(1.3–1.7)
|
|
3
|
3
|
0
|
0
|
8.2
|
(7.7–8.6)
|
8.1
|
(7.7–8.5)
|
|
4
|
3
|
1
|
0
|
1.6
|
(1.4–1.8)
|
0.6
|
(0.5–0.8)
|
|
4
|
4
|
0
|
0
|
5.0
|
(4.6–5.4)
|
7.2
|
(6.8–7.6)
|
|
All inconsistent positive screens
|
17.5*
|
(16.8–18.1)
|
17.4
|
(16.9–18.0)
|
|
Negative screen based on AUDIT-C score
|
|
AUDIT-C score
|
% reporting > recommended limits
|
|
Total
|
Q#1
|
Q#2
|
Q#3
|
%
|
(95% CI)
|
%
|
(95% CI)
|
|
2
|
1
|
0
|
1
|
0.8
|
(0.7–1.0)
|
3.3
|
(3.0–3.6)
|
|
All inconsistent negative screens
|
0.8
|
(0.7–1.0)
|
3.3
|
(3.0–3.6)
|
|
All inconsistent negative & positive screens
|
18.3*
|
(17.7–18.9)
|
20.7
|
(20.1–21.3)
|
